Department of Pharmacology, MKCG Medical College, Berhampur, Odisha, India.
Indian J Pharmacol. 2024 Mar 1;56(2):112-119. doi: 10.4103/ijp.ijp_210_23. Epub 2024 Apr 30.
Ixora coccinea leaves possess antioxidant, anti-inflammatory, antinociceptive, antimutagenic, and gastroprotective properties. On this background, its antiarthritic potential was evaluated.
The objective is to evaluate the effect of Ethanolic extract of Ixora coccinea leaves (EEICL) on complete Freund's adjuvant-induced arthritis in rats.
PG research laboratory, Pharmacology Department, MKCG Medical College, Berhampur, Odisha.
Thirty-six Wistar albino rats were randomly distributed into sixgroups (n = 6) as follows: Gr 1 (normal control)-DW p.o, Gr-2 (disease control [DC] - Tween 80 p.o), Gr-3 (piroxicam 0.9 mg/kg p.o), Gr-4 (EEICL-1 g/kg, p.o, Gr 4-EEICL-1.5 g/kg p.o, Gr 5-ED50 (0.82 g/kg) + piroxicam (0.45 mg/kg) p.o. After induction of arthritis, drugs, and vehicles were administered daily from 5th to 25th day. On 0, 5th, 10th, 15th, and 25th day, parameters like body weight, rotarod fall time, paw volume displacement, and arthritis index were measured. On the last day, Erythrocyte sedimentation rate (ESR), tissue malondialdehyde (MDA), and histopathological analysis were done.
Analysis of parametric data was done by one-way ANOVA and nonparametric data by Kruskal-Wallis test using graph pad prism 7.0. P < 0.05 was considered statistically significant.
EEICL (1.5 mg/kg) showed anti-arthritic effect compared with DC. Rotarod fall-off time 137.5 ± 2.5 sec and body weight (139 ± 12.74 g) were increased significantly. The percentage inhibition of paw volume was increased(52%) whereas arthritic score(0.33), ESR(3.51mm/hr), synovial tissue MDA level (0.62±0.13µmol/gm) and Mankin score(2) were reduced significantly as compared to disease control.
EEICL has anti-arthritic potential in rat model.
宝巾叶具有抗氧化、抗炎、镇痛、抗突变和胃保护作用。在此背景下,评估了其抗关节炎的潜力。
目的是评估依诺沙星叶乙醇提取物(EEICL)对完全弗氏佐剂诱导的关节炎大鼠的影响。
PG 研究实验室,药理学系,MKCG 医学院,奥里萨邦,伯汉普尔。
36 只 Wistar 白化大鼠随机分为六组(n = 6)如下:Gr1(正常对照)-DW po,Gr-2(疾病对照[DC]-吐温 80 po),Gr-3(吡罗昔康 0.9 mg/kg po),Gr-4(EEICL-1 g/kg po,Gr 4-EEICL-1.5 g/kg po),Gr 5-ED50(0.82 g/kg)+吡罗昔康(0.45 mg/kg)po。关节炎诱导后,从第 5 天到第 25 天每天给予药物和载体。在第 0、5、10、15 和 25 天,测量体重、旋转棒跌落时间、爪体积位移和关节炎指数等参数。在最后一天,进行红细胞沉降率(ESR)、组织丙二醛(MDA)和组织学分析。
使用 Graph Pad Prism 7.0 对参数数据进行单因素方差分析,对非参数数据进行 Kruskal-Wallis 检验。P < 0.05 被认为具有统计学意义。
EEICL(1.5 mg/kg)与 DC 相比显示出抗关节炎作用。旋转棒跌落时间为 137.5 ± 2.5 秒,体重(139 ± 12.74 克)明显增加。爪体积的抑制百分比增加(52%),而关节炎评分(0.33)、ESR(3.51mm/hr)、滑膜组织 MDA 水平(0.62±0.13µmol/gm)和 Mankin 评分(2)与疾病对照组相比明显降低。
EEICL 在大鼠模型中具有抗关节炎潜力。